259 related articles for article (PubMed ID: 21859674)
1. Transcriptional and posttranscriptional control of cholesterol homeostasis by liver X receptors.
Tontonoz P
Cold Spring Harb Symp Quant Biol; 2011; 76():129-37. PubMed ID: 21859674
[TBL] [Abstract][Full Text] [Related]
2. Liver X receptors as integrators of metabolic and inflammatory signaling.
Zelcer N; Tontonoz P
J Clin Invest; 2006 Mar; 116(3):607-14. PubMed ID: 16511593
[TBL] [Abstract][Full Text] [Related]
3. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
[TBL] [Abstract][Full Text] [Related]
4. Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis.
Zhang L; Reue K; Fong LG; Young SG; Tontonoz P
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2541-6. PubMed ID: 22936343
[TBL] [Abstract][Full Text] [Related]
5. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.
Zelcer N; Hong C; Boyadjian R; Tontonoz P
Science; 2009 Jul; 325(5936):100-4. PubMed ID: 19520913
[TBL] [Abstract][Full Text] [Related]
6. Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis.
Sallam T; Jones MC; Gilliland T; Zhang L; Wu X; Eskin A; Sandhu J; Casero D; Vallim TQ; Hong C; Katz M; Lee R; Whitelegge J; Tontonoz P
Nature; 2016 Jun; 534(7605):124-8. PubMed ID: 27251289
[TBL] [Abstract][Full Text] [Related]
7. Liver X receptors in lipid signalling and membrane homeostasis.
Wang B; Tontonoz P
Nat Rev Endocrinol; 2018 Aug; 14(8):452-463. PubMed ID: 29904174
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitylase Inhibition Reveals Liver X Receptor-independent Transcriptional Regulation of the E3 Ubiquitin Ligase IDOL and Lipoprotein Uptake.
Nelson JK; Cook EC; Loregger A; Hoeksema MA; Scheij S; Kovacevic I; Hordijk PL; Ovaa H; Zelcer N
J Biol Chem; 2016 Feb; 291(9):4813-25. PubMed ID: 26719329
[TBL] [Abstract][Full Text] [Related]
9. Role of liver X receptors in cholesterol efflux and inflammatory signaling (review).
Zhu R; Ou Z; Ruan X; Gong J
Mol Med Rep; 2012 Apr; 5(4):895-900. PubMed ID: 22267249
[TBL] [Abstract][Full Text] [Related]
10. [Recent advances on liver X receptors].
Wang Q; Jiang Y
Sheng Li Ke Xue Jin Zhan; 2009 Apr; 40(2):147-50. PubMed ID: 19558144
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression.
Pascual-García M; Rué L; León T; Julve J; Carbó JM; Matalonga J; Auer H; Celada A; Escolà-Gil JC; Steffensen KR; Pérez-Navarro E; Valledor AF
J Immunol; 2013 Jun; 190(12):6520-32. PubMed ID: 23686490
[TBL] [Abstract][Full Text] [Related]
12. LuXuRies of lipid homeostasis: the unity of nuclear hormone receptors, transcription regulation, and cholesterol sensing.
Zhang Y; Mangelsdorf DJ
Mol Interv; 2002 Apr; 2(2):78-87. PubMed ID: 14993353
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptors bridge hepatic lipid metabolism and inflammation.
Liu Y; Qiu DK; Ma X
J Dig Dis; 2012 Feb; 13(2):69-74. PubMed ID: 22257474
[TBL] [Abstract][Full Text] [Related]
14. Regulation of intestinal LDLR by the LXR-IDOL axis.
van Loon NM; van Wouw SAE; Ottenhoff R; Nelson JK; Kingma J; Scheij S; Moeton M; Zelcer N
Atherosclerosis; 2020 Dec; 315():1-9. PubMed ID: 33190106
[TBL] [Abstract][Full Text] [Related]
15. Liver X receptors as potential therapeutic targets in atherosclerosis.
Zhu Y; Li Y
Clin Invest Med; 2009 Oct; 32(5):E383-94. PubMed ID: 19796580
[TBL] [Abstract][Full Text] [Related]
16. Liver X receptor in cholesterol metabolism.
Zhao C; Dahlman-Wright K
J Endocrinol; 2010 Mar; 204(3):233-40. PubMed ID: 19837721
[TBL] [Abstract][Full Text] [Related]
17. Liver X receptor signaling pathways in cardiovascular disease.
Tontonoz P; Mangelsdorf DJ
Mol Endocrinol; 2003 Jun; 17(6):985-93. PubMed ID: 12690094
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis.
Millatt LJ; Bocher V; Fruchart JC; Staels B
Biochim Biophys Acta; 2003 Mar; 1631(2):107-18. PubMed ID: 12633677
[TBL] [Abstract][Full Text] [Related]
19. Lipids, LXRs and prostate cancer: are HDACs a new link?
Hoang JJ; Baron S; Volle DH; Lobaccaro JM; Trousson A
Biochem Pharmacol; 2013 Jul; 86(1):168-74. PubMed ID: 23618920
[TBL] [Abstract][Full Text] [Related]
20. Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer.
Bovenga F; Sabbà C; Moschetta A
Cell Metab; 2015 Apr; 21(4):517-26. PubMed ID: 25863245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
